Skip to main content

Bronchiolitis

  • Chapter
  • First Online:
Diffuse Lung Disease

Abstract

Bronchiolitis is defined as an inflammatory process involving the bronchioles that may be associated with fibrosis of the bronchiolar wall. Bronchiolitis may be classified according to its etiology, onset (acute or chronic), or pathology. Cellular bronchiolitis corresponds to the infiltration of bronchiolar walls by inflammatory cells. Bronchiolitis obliterans is characterized by the narrowing of the caliber of the bronchiole as a consequence of fibrosis, with constrictive bronchiolitis obliterans consisting of concentric fibrosis in the wall of the bronchiole and narrowing of the bronchiolar lumen, and proliferative bronchiolitis obliterans (found in association with organizing pneumonia) characterized by buds of granulation tissue within the lumen of the bronchiole. Bronchiolitis that reduces the caliber of the small airways (constrictive bronchiolitis) typically results in nonreversible airflow obstruction. Characteristic features of bronchiolar disease on high-resolution tomography of the chest consist of a combination of centrilobular nodules, V- or Y-shaped branching linear opacities (tree-in-bud pattern), bronchiolar dilation, and the mosaic attenuation pattern on expiratory images. The main determined causes of bronchiolitis include infection especially due to respiratory syncytial virus (RSV), acute inhalational injury by toxic gases or fumes, drugs (penicillamine), intake of juice from Sauropus androgynus, and occupational exposures (asbestos, nonasbestos mineral dusts, inhaled diacetyl used as butter-flavoring ingredients in microwave-popcorn plants, synthetic polymers in industrial flockers). Bronchiolitis may further occur in well-characterized contexts, especially in rheumatoid arthritis, Sjögren syndrome, following lung transplantation or bone marrow graft, and rarely in paraneoplastic pemphigus. Cryptogenic constrictive bronchiolitis is a rare cause of airflow obstruction predominating in females between 40 and 60 year old. Bronchiolitis may also be observed as an associated pathological finding in a variety of conditions affecting the airways (chronic obstructive pulmonary disease, bronchiectasis, respiratory bronchiolitis) or as a component of diffuse inflammatory lung disease. Management of bronchiolitis depends on the etiological context, pathologic pattern, severity of impairment of pulmonary function, and progression of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Visscher DW, Myers JL. Bronchiolitis: the pathologist’s perspective. Proc Am Thorac Soc. 2006;3:41–7.

    Article  PubMed  Google Scholar 

  2. Rice A, Nicholson AG. The pathologist’s approach to small airways disease. Histopathology. 2009;54: 117–33.

    Article  PubMed  Google Scholar 

  3. Cordier JF. Challenges in pulmonary fibrosis. 2: Bronchiolocentric fibrosis. Thorax. 2007;62:638–49.

    Article  PubMed  Google Scholar 

  4. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med. 2002;165:277–304.

    Google Scholar 

  5. Stanescu D. Small airways obstruction syndrome. Chest. 1999;116:231–3.

    Article  PubMed  CAS  Google Scholar 

  6. Reynaud-Gaubert M, Thomas P, Badier M, et al. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings. Am J Respir Crit Care Med. 2000;161:1924–9.

    PubMed  CAS  Google Scholar 

  7. Lynch DA. Imaging of small airways disease and chronic obstructive pulmonary disease. Clin Chest Med. 2008;29:165–79, vii.

    Google Scholar 

  8. Kang EY, Woo OH, Shin BK, et al. Bronchiolitis: classification, computed tomographic and histopathologic features, and radiologic approach. J Comput Assist Tomogr. 2009;33:32–41.

    Article  PubMed  Google Scholar 

  9. Pipavath SJ, Lynch DA, Cool C, et al. Radiologic and pathologic features of bronchiolitis. AJR Am J Roentgenol. 2005;185:354–63.

    PubMed  Google Scholar 

  10. Crosbie PA, Woodhead MA. Long-term macrolide therapy in chronic inflammatory airway diseases. Eur Respir J. 2009;33:171–81.

    Article  PubMed  CAS  Google Scholar 

  11. Idris SF, Chilvers ER, Haworth C, et al. Azithromycin therapy for neutrophilic airways disease: myth or magic? Thorax. 2009;64:186–9.

    Article  PubMed  Google Scholar 

  12. Bush A, Thomson AH. Acute bronchiolitis. BMJ. 2007;335:1037–41.

    Article  PubMed  Google Scholar 

  13. Tahan F, Ozcan A, Koc N. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J. 2007;29:91–7.

    Article  PubMed  CAS  Google Scholar 

  14. Wong JY, Rutman A, O’Callaghan C. Recovery of the ciliated epithelium following acute bronchiolitis in infancy. Thorax. 2005;60:582–7.

    Article  PubMed  CAS  Google Scholar 

  15. Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med. 2005;171:137–41.

    Article  PubMed  Google Scholar 

  16. Jeong YJ, Lee KS, Koh WJ, et al. Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-section CT and histopathologic findings. Radiology. 2004;231: 880–6.

    Article  PubMed  Google Scholar 

  17. Okada F, Ando Y, Yoshitake S, et al. Pulmonary CT findings in 320 carriers of human T-lymphotropic virus type 1. Radiology. 2006;240:559–64.

    Article  PubMed  Google Scholar 

  18. Chang AB, Masel JP, Masters B. Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae. Pediatr Radiol. 1998;28:23–9.

    Article  PubMed  CAS  Google Scholar 

  19. Zhang L, Irion K, Kozakewich H, et al. Clinical course of postinfectious bronchiolitis obliterans. Pediatr Pulmonol. 2000;29:341–50.

    Article  PubMed  CAS  Google Scholar 

  20. Mauad T, Dolhnikoff M. Histology of childhood bronchiolitis obliterans. Pediatr Pulmonol. 2002;33: 466–74.

    Article  PubMed  Google Scholar 

  21. Koh YY, da Jung E, Koh JY, et al. Bronchoalveolar cellularity and interleukin-8 levels in measles bronchiolitis obliterans. Chest. 2007;131:1454–60.

    Article  PubMed  CAS  Google Scholar 

  22. Hardy KA, Schidlow DV, Zaeri N. Obliterative bronchiolitis in children. Chest. 1988;93:460–6.

    Article  PubMed  CAS  Google Scholar 

  23. Zwemer Jr FL, Pratt DS, May JJ. Silo filler’s disease in New York State. Am Rev Respir Dis. 1992;146: 650–3.

    PubMed  Google Scholar 

  24. Ghanei M, Tazelaar HD, Chilosi M, et al. An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. Respir Med. 2008;102:825–30.

    Article  PubMed  Google Scholar 

  25. Ghanei M, Mokhtari M, Mohammad MM, et al. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol. 2004;52:164–9.

    Article  PubMed  Google Scholar 

  26. Lai RS, Chiang AA, Wu MT, et al. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet. 1996;348: 83–5.

    Article  PubMed  CAS  Google Scholar 

  27. Yang CF, Wu MT, Chiang AA, et al. Correlation of high-resolution CT and pulmonary function in bronchiolitis obliterans: a study based on 24 patients associated with consumption of Sauropus androgynus. AJR Am J Roentgenol. 1997;168:1045–50.

    PubMed  CAS  Google Scholar 

  28. Oonakahara K, Matsuyama W, Higashimoto I, et al. Outbreak of Bronchiolitis obliterans associated with consumption of Sauropus androgynus in Japan–alert of food-associated pulmonary disorders from Japan. Respiration. 2005;72:221.

    Article  PubMed  Google Scholar 

  29. Wright JL, Cagle P, Churg A, et al. Diseases of the small airways. Am Rev Respir Dis. 1992;146:240–62.

    PubMed  CAS  Google Scholar 

  30. Kreiss K, Gomaa A, Kullman G, et al. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med. 2002;347:330–8.

    Article  PubMed  Google Scholar 

  31. Kanwal R, Kullman G, Piacitelli C, et al. Evaluation of flavorings-related lung disease risk at six microwave popcorn plants. J Occup Environ Med. 2006;48:149–57.

    Article  PubMed  CAS  Google Scholar 

  32. van Rooy FG, Rooyackers JM, Prokop M, et al. Bronchiolitis obliterans syndrome in chemical workers producing diacetyl for food flavorings. Am J Respir Crit Care Med. 2007;176:498–504.

    Article  PubMed  Google Scholar 

  33. Kreiss K. Occupational bronchiolitis obliterans masquerading as COPD. Am J Respir Crit Care Med. 2007;176:427–9.

    Article  PubMed  Google Scholar 

  34. Eschenbacher WL, Kreiss K, Lougheed MD, et al. Nylon flock-associated interstitial lung disease. Am J Respir Crit Care Med. 1999;159:2003–8.

    PubMed  CAS  Google Scholar 

  35. Atis S, Tutluoglu B, Levent E, et al. The respiratory effects of occupational polypropylene flock exposure. Eur Respir J. 2005;25:110–7.

    Article  PubMed  CAS  Google Scholar 

  36. Weiland DA, Lynch DA, Jensen SP, et al. Thin-section CT findings in flock worker’s lung, a work-related interstitial lung disease. Radiology. 2003;227:222–31.

    Article  PubMed  Google Scholar 

  37. Konichezky S, Schattner A, Ezri T, et al. Thionyl-chloride-induced lung injury and bronchiolitis obliterans. Chest. 1993;104:971–3.

    Article  PubMed  CAS  Google Scholar 

  38. Epler GR, Snider GL, Gaensler EA, et al. Bronchiolitis and bronchitis in connective tissue disease. A possible relationship to the use of penicillamine. JAMA. 1979;242:528–32.

    Article  PubMed  CAS  Google Scholar 

  39. Geddes DM, Corrin B, Brewerton DA, et al. Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med. 1977;46: 427–44.

    PubMed  CAS  Google Scholar 

  40. Devouassoux G, Cottin V, Liote H, et al. Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis. Eur Respir J. 2009;33:1053–61.

    Article  PubMed  CAS  Google Scholar 

  41. Parambil JG, Yi ES, Ryu JH. Obstructive bronchiolar disease identified by CT in the non-transplant population: analysis of 29 consecutive cases. Respirology. 2009;14:443–8.

    Article  PubMed  Google Scholar 

  42. Tanaka N, Kim JS, Newell JD, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology. 2004;232:81–91.

    Article  PubMed  Google Scholar 

  43. Wolfe F, Schurle DR, Lin JJ, et al. Upper and lower airway disease in penicillamine treated patients with rheumatoid arthritis. J Rheumatol. 1983;10:406–10.

    PubMed  CAS  Google Scholar 

  44. Papiris SA, Maniati M, Constantopoulos SH, et al. Lung involvement in primary Sjogren’s syndrome is mainly related to the small airway disease. Ann Rheum Dis. 1999;58:61–4.

    Article  PubMed  CAS  Google Scholar 

  45. Tzeng DZ, Leslie KO, Shelton D, et al. Unusual dyspnea in a woman with CREST syndrome. Chest. 2008;133:286–90.

    Article  PubMed  Google Scholar 

  46. Boehler A, Vogt P, Speich R, et al. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine. Eur Respir J. 1996;9:1317–9.

    Article  PubMed  CAS  Google Scholar 

  47. Weigt SS, Wallace WD, Derhovanessian A, et al. Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment. Semin Respir Crit Care Med. 2010;31:189–207.

    Article  PubMed  Google Scholar 

  48. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007;26:1229–42.

    Article  PubMed  Google Scholar 

  49. Knoop C, Estenne M. Acute and chronic rejection after lung transplantation. Semin Respir Crit Care Med. 2006;27:521–33.

    Article  PubMed  Google Scholar 

  50. Jackson CH, Sharples LD, McNeil K, et al. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? J Heart Lung Transplant. 2002;21:658–66.

    Article  PubMed  Google Scholar 

  51. Belperio JA, Weigt SS, Fishbein MC, et al. Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc. 2009;6:108–21.

    Article  PubMed  CAS  Google Scholar 

  52. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant. 2002;21:297–310.

    Article  PubMed  Google Scholar 

  53. Quantz MA, Bennett LE, Meyer DM, et al. Does human leukocyte antigen matching influence the outcome of lung transplantation? An analysis of 3,549 lung transplantations. J Heart Lung Transplant. 2000;19:473–9.

    Article  PubMed  CAS  Google Scholar 

  54. Glanville AR, Aboyoun CL, Havryk A, et al. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med. 2008;177:1033–40.

    Article  PubMed  Google Scholar 

  55. Bankier AA, Van Muylem A, Knoop C, et al. Bronchiolitis obliterans syndrome in heart-lung transplant recipients: diagnosis with expiratory CT. Radiology. 2001;218: 533–9.

    PubMed  CAS  Google Scholar 

  56. Glanville AR. The role of bronchoscopic surveillance monitoring in the care of lung transplant recipients. Semin Respir Crit Care Med. 2006;27:480–91.

    Article  PubMed  Google Scholar 

  57. Martinu T, Howell DN, Davis RD, et al. Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients. Chest. 2006;129:1016–23.

    Article  PubMed  Google Scholar 

  58. Jain R, Hachem RR, Morrell MR, et al. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant. 2010;29:531–7.

    Article  PubMed  Google Scholar 

  59. Vanaudenaerde BM, Meyts I, Vos R, et al. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J. 2008;32:832–43.

    Article  PubMed  CAS  Google Scholar 

  60. Iacono AT, Johnson BA, Grgurich WF, et al. A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med. 2006;354:141–50.

    Article  PubMed  Google Scholar 

  61. Brugiere O, Thabut G, Castier Y, et al. Lung retransplantation for bronchiolitis obliterans syndrome: long-term follow-up in a series of 15 recipients. Chest. 2003;123:1832–7.

    Article  PubMed  Google Scholar 

  62. Yoshihara S, Tateishi U, Ando T, et al. Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning. Bone Marrow Transplant. 2005;35: 1195–200.

    Article  PubMed  CAS  Google Scholar 

  63. Soubani AO, Uberti JP. Bronchiolitis obliterans following haematopoietic stem cell transplantation. Eur Respir J. 2007;29:1007–19.

    Article  PubMed  CAS  Google Scholar 

  64. Williams KM, Chien JW, Gladwin MT, et al. Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation. JAMA. 2009;302:306–14.

    Article  PubMed  CAS  Google Scholar 

  65. Philit F, Wiesendanger T, Archimbaud E, et al. Post-transplant obstructive lung disease (“bronchiolitis obliterans”): a clinical comparative study of bone marrow and lung transplant patients. Eur Respir J. 1995;8:551–8.

    PubMed  CAS  Google Scholar 

  66. Yousem SA. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol. 1995;26:668–75.

    Article  PubMed  CAS  Google Scholar 

  67. Clark JG, Crawford SW, Madtes DK, et al. Obstructive lung disease after allogeneic marrow transplantation. Clinical presentation and course. Ann Intern Med. 1989;111:368–76.

    PubMed  CAS  Google Scholar 

  68. Khalid M, Al Saghir A, Saleemi S, et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J. 2005;25:490–3.

    Article  PubMed  CAS  Google Scholar 

  69. Nikolskaia OV, Nousari CH, Anhalt GJ. Paraneoplastic pemphigus in association with Castleman’s disease. Br J Dermatol. 2003;149:1143–51.

    Article  PubMed  CAS  Google Scholar 

  70. Maldonado F, Pittelkow MR, Ryu JH. Constrictive bronchiolitis associated with paraneoplastic autoimmune multi-organ syndrome. Respirology. 2009;14: 129–33.

    Article  PubMed  Google Scholar 

  71. Kraft M, Mortenson RL, Colby TV, et al. Cryptogenic constrictive bronchiolitis. A clinicopathologic study. Am Rev Respir Dis. 1993;148:1093–101.

    Article  PubMed  CAS  Google Scholar 

  72. Dorinsky PM, Davis WB, Lucas JG, et al. Adult bronchiolitis. Evaluation by bronchoalveolar lavage and response to prednisone therapy. Chest. 1985;88:58–63.

    Article  PubMed  CAS  Google Scholar 

  73. Turton CW, Williams G, Green M. Cryptogenic obliterative bronchiolitis in adults. Thorax. 1981;36:805–10.

    Article  PubMed  CAS  Google Scholar 

  74. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733–43.

    Article  PubMed  Google Scholar 

  75. Hogg JC. State of the art. Bronchiolitis in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3:489–93.

    Article  PubMed  CAS  Google Scholar 

  76. Niewoehner DE, Kleinerman J, Rice DB. Pathologic changes in the peripheral airways of young cigarette smoker’s. N Engl J Med. 1974;291:755–8.

    Article  PubMed  CAS  Google Scholar 

  77. Fraig M, Shreesha U, Savici D, et al. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol. 2002;26:647–53.

    Article  PubMed  Google Scholar 

  78. Galvin JR, Franks TJ. Smoking-related lung disease. J Thorac Imaging. 2009;24:274–84.

    Article  PubMed  Google Scholar 

  79. Wells AU, Nicholson AG, Hansell DM. Challenges in pulmonary fibrosis. 4: smoking-induced diffuse interstitial lung diseases. Thorax. 2007;62:904–10.

    Article  PubMed  Google Scholar 

  80. Heyneman LE, Ward S, Lynch DA, et al. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process? AJR Am J Roentgenol. 1999;173:1617–22.

    PubMed  CAS  Google Scholar 

  81. Craig PJ, Wells AU, Doffman S, et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology. 2004; 45:275–82.

    Article  PubMed  CAS  Google Scholar 

  82. Ryu JH, Myers JL, Capizzi SA, et al. Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease. Chest. 2005;127: 178–84.

    Article  PubMed  Google Scholar 

  83. Portnoy J, Veraldi KL, Schwarz MI, et al. Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest. 2007;131:664–71.

    Article  PubMed  Google Scholar 

  84. Barnes PJ. Small airways in COPD. N Engl J Med. 2004;350:2635–7.

    Article  PubMed  CAS  Google Scholar 

  85. Leopold JG, Gough J. The centrilobular form of hypertrophic emphysema and its relation to chronic bronchitis. Thorax. 1957;12:219–35.

    Article  PubMed  CAS  Google Scholar 

  86. Aerni MR, Vassallo R, Myers JL, et al. Follicular bronchiolitis in surgical lung biopsies: clinical implications in 12 patients. Respir Med. 2008;102: 307–12.

    Article  PubMed  Google Scholar 

  87. Romero S, Barroso E, Gil J, et al. Follicular bronchiolitis: clinical and pathologic findings in six patients. Lung. 2003;181:309–19.

    Article  PubMed  CAS  Google Scholar 

  88. Kang EY, Miller RR, Muller NL. Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiology. 1995;195:649–54.

    PubMed  CAS  Google Scholar 

  89. Hansell DM, Wells AU, Rubens MB, et al. Bronchiectasis: functional significance of areas of decreased attenuation at expiratory CT. Radiology. 1994;193:369–74.

    PubMed  CAS  Google Scholar 

  90. Roberts HR, Wells AU, Milne DG, et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax. 2000;55:198–204.

    Article  PubMed  CAS  Google Scholar 

  91. Sheehan RE, Wells AU, Copley SJ, et al. A comparison of serial computed tomography and functional change in bronchiectasis. Eur Respir J. 2002;20:581–7.

    Article  PubMed  CAS  Google Scholar 

  92. Sobonya RE, Taussig LM. Quantitative aspects of lung pathology in cystic fibrosis. Am Rev Respir Dis. 1986;134:290–5.

    PubMed  CAS  Google Scholar 

  93. Helbich TH, Heinz-Peer G, Eichler I, et al. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology. 1999;213:537–44.

    PubMed  CAS  Google Scholar 

  94. Homma S, Kawabata M, Kishi K, et al. Bronchiolitis in Kartagener’s syndrome. Eur Respir J. 1999;14:1332–9.

    Article  PubMed  CAS  Google Scholar 

  95. Poletti V, Casoni G, Chilosi M, et al. Diffuse panbronchiolitis. Eur Respir J. 2006;28:862–71.

    Article  PubMed  CAS  Google Scholar 

  96. Poletti V, Chilosi M, Trisolini R, et al. Idiopathic bronchiolitis mimicking diffuse panbronchiolitis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:62–8.

    PubMed  Google Scholar 

  97. Davies SJ, Gosney JR, Hansell DM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax. 2007;62:248–52.

    Article  PubMed  Google Scholar 

  98. Naccache JM, Lavole A, Nunes H, et al. High-resolution computed tomographic imaging of airways in sarcoidosis patients with airflow obstruction. J Comput Assist Tomogr. 2008;32:905–12.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-François Cordier MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Cottin, V., Cordier, JF. (2012). Bronchiolitis. In: Baughman, R., du Bois, R. (eds) Diffuse Lung Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9771-5_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-9771-5_18

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-9770-8

  • Online ISBN: 978-1-4419-9771-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics